Clopidogrel indications: Difference between revisions
Varun Kumar (talk | contribs) No edit summary |
Matt Pijoan (talk | contribs) m Protected "Clopidogrel indications": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
(No difference)
| |
Revision as of 16:46, 27 September 2011
List of indications
Plavix (clopidogrel bisulfate) is indicated for the reduction of atherothrombotic events as follows:
Recent MI, Recent Stroke or Established Peripheral Arterial Disease
Acute Coronary Syndrome
Recent MI, Recent Stroke or Established Peripheral Arterial Disease
For patients with a history of recent myocardial infarction (MI), recent [[stroke], or established peripheral arterial disease, clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new MI (fatal or not), and other vascular death.
Acute Coronary Syndrome
For patients with acute coronary syndrome (unstable angina / non-Q-wave MI) including patients who are to be managed medically and those who are to be managed with percutaneous coronary intervention (with or without stent) or CABG, clopidogrel has been shown to decrease the rate of a combined endpoint of cardiovascular death, MI, or stroke as well as the rate of a combined endpoint of cardiovascular death, MI, stroke, or refractory ischemia
Adapted from the FDA Package Insert.